StockData
Biogen Inc. logo

Biogen Inc. (BIIB) stock

BIIBNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 4/3057% above fair value
$251.41+0.62 (+0.25%)

Close on Nov 18, 2026Market cap $37.16BP/E 107.4Yield –

Biogen total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Biogen's total debt was $6.29B at Dec 31, 2025. For fiscal 2025 it was $6.29B, down 0.1% from the year before. Over ten years it grew 75.3% a year on average. The highest annual figure on record is $8.57B in fiscal 2021.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$6.29B-0.1%
FY2024Dec 31, 2024$6.30B-9.3%
FY2023Dec 31, 2023$6.94B+10.5%
FY2022Dec 31, 2022$6.28B-26.7%
FY2021Dec 31, 2021$8.57B+14.2%
FY2020Dec 31, 2020$7.50B+0.1%
FY2019Dec 31, 2019$7.50B+24.9%
FY2018Dec 31, 2018$6.00B+187400.0%
FY2017Dec 31, 2017$3.20M-84.8%
FY2016Dec 31, 2016$21.10M-7.9%
FY2015Dec 31, 2015$22.90M+638.7%
FY2014Dec 31, 2014$3.10M-99.5%
FY2013Dec 31, 2013$571.39M-49.9%
FY2012Dec 31, 2012$1.14B+7.5%
FY2011Dec 31, 2011$1.06B-0.5%
FY2010Dec 31, 2010$1.07B-1.3%
FY2009Dec 31, 2009$1.08B-0.5%
FY2008Dec 31, 2008$1.09B–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2025Dec 31, 2025$6.29B-26.6%
Q4 FY2024Dec 31, 2024$6.30B-16.1%
Q4 FY2023Dec 31, 2023$6.94B-7.4%
Q4 FY2022Dec 31, 2022$6.28B+4.7%
Q4 FY2021Dec 31, 2021$8.57B–
Q4 FY2020Dec 31, 2020$7.50B–
Q4 FY2019Dec 31, 2019$7.50B+227045.5%
Q4 FY2018Dec 31, 2018$6.00B+187400.0%
Q3 FY2018Sep 30, 2018$0-100.0%
Q2 FY2018Jun 30, 2018$0-100.0%
Q1 FY2018Mar 31, 2018$3.30M-99.4%
Q4 FY2017Dec 31, 2017$3.20M-84.8%
Q3 FY2017Sep 30, 2017$573.20M–
Q2 FY2017Jun 30, 2017$559.90M–
Q1 FY2017Mar 31, 2017$561.50M–
Q4 FY2016Dec 31, 2016$21.10M–

More Biogen figures

See a number that looks wrong?